NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells.

Cancer research(2023)

引用 8|浏览56
暂无评分
摘要
NFE2L2 mutations are predictive biomarkers of radioresistance in head and neck cancer and confer sensitivity to glutaminase inhibitors to overcome radioresistance.
更多
查看译文
关键词
<i>nfe2l2</i>mutations enhance radioresistance,neck cancer,modulating intratumoral myeloid cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要